Drug intelligence / Profile preview

16-[18F]fluoro-4-thiapalmitate

Development stage
Unknown
Lead developer
Indiana University School of Medicine
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

16-[18F]fluoro-4-thiapalmitate (18F-FTP) is a small-molecule positron emission tomography (PET) radiopharmaceutical developed by Indiana University. It serves as a metabolically trapped analog of palmitate, designed to assess myocardial fatty acid oxidation (FAO) rates. The tracer's mechanism involves transport into the mitochondria via carnitine palmitoyl-transferase-I (CPT-1), where it undergoes partial beta-oxidation but becomes trapped, allowing for the quantification of fatty acid metabolism. It is primarily used as a diagnostic research tool to study myocardial fuel selection in conditions such as Type 2 Diabetes (T2DM), ischemic heart disease, and nonischemic cardiac diseases.

Other names
16-fluoro-4-thiapalmitatethiapalmitate16-18-F-fluoro-4-thiapalmitate
02

Targets

SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on 16-[18F]fluoro-4-thiapalmitate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16-[18F]fluoro-4-thiapalmitate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call